A detailed history of Hancock Whitney Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Hancock Whitney Corp holds 18,405 shares of ABT stock, worth $2.17 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
18,405
Previous 19,395 5.1%
Holding current value
$2.17 Million
Previous $2.02 Million 4.12%
% of portfolio
0.07%
Previous 0.07%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $99,069 - $116,948
-990 Reduced 5.1%
18,405 $2.1 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $260,387 - $290,657
-2,585 Reduced 11.76%
19,395 $2.02 Million
Q1 2024

May 16, 2024

SELL
$109.52 - $120.96 $369,410 - $407,998
-3,373 Reduced 13.3%
21,980 $2.5 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $112,647 - $137,889
1,249 Added 5.18%
25,353 $2.79 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $1 Million - $1.2 Million
-10,508 Reduced 30.36%
24,104 $2.33 Million
Q2 2023

Nov 13, 2023

BUY
$100.78 - $112.29 $267,570 - $298,129
2,655 Added 8.31%
34,612 $3.77 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $267,570 - $298,129
2,655 Added 8.31%
34,612 $3.77 Million
Q1 2023

Nov 13, 2023

SELL
$96.86 - $114.01 $30,607 - $36,027
-316 Reduced 0.98%
31,957 $3.24 Million
Q1 2023

May 16, 2023

SELL
$96.86 - $114.01 $30,607 - $36,027
-316 Reduced 0.98%
31,957 $3.24 Million
Q4 2022

Nov 13, 2023

SELL
$95.06 - $111.52 $222,345 - $260,845
-2,339 Reduced 6.76%
32,273 $3.54 Million
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $97,626 - $114,531
1,027 Added 3.29%
32,273 $3.54 Million
Q3 2022

Oct 26, 2022

SELL
$96.76 - $112.03 $19,545 - $22,630
-202 Reduced 0.64%
31,246 $3.02 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $12,758 - $15,421
-125 Reduced 0.4%
31,448 $3.42 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $65,561 - $79,948
575 Added 1.85%
31,573 $3.74 Million
Q4 2021

Jan 25, 2022

BUY
$115.53 - $141.46 $292,637 - $358,318
2,533 Added 8.9%
30,998 $4.36 Million
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $25,665 - $28,393
-220 Reduced 0.77%
28,465 $3.36 Million
Q2 2021

Aug 09, 2021

SELL
$105.79 - $124.53 $236,229 - $278,075
-2,233 Reduced 7.22%
28,685 $3.33 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $42,338 - $49,881
-389 Reduced 1.24%
30,918 $3.71 Million
Q4 2020

Feb 09, 2021

SELL
$105.0 - $114.42 $831,915 - $906,549
-7,923 Reduced 20.2%
31,307 $3.43 Million
Q3 2020

Nov 05, 2020

BUY
$91.64 - $111.29 $1,649 - $2,003
18 Added 0.05%
39,230 $4.27 Million
Q2 2020

Jul 30, 2020

SELL
$76.57 - $98.0 $47,167 - $60,368
-616 Reduced 1.55%
39,212 $3.58 Million
Q1 2020

May 08, 2020

SELL
$62.82 - $91.86 $55,407 - $81,020
-882 Reduced 2.17%
39,828 $3.14 Million
Q4 2019

Feb 06, 2020

SELL
$78.51 - $87.4 $772,773 - $860,278
-9,843 Reduced 19.47%
40,710 $3.54 Million
Q3 2019

Oct 29, 2019

SELL
$81.84 - $88.74 $588,347 - $637,951
-7,189 Reduced 12.45%
50,553 $4.23 Million
Q2 2019

Aug 29, 2019

BUY
$72.88 - $85.0 $399,163 - $465,545
5,477 Added 10.48%
57,742 $4.86 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $45,625 - $55,161
-689 Reduced 1.3%
52,265 $4.18 Million
Q4 2018

Feb 15, 2019

BUY
$65.56 - $74.27 $694,083 - $786,296
10,587 Added 24.99%
52,954 $3.83 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $1.5 Million - $1.81 Million
24,632 Added 138.89%
42,367 $3.11 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $64,766 - $71,482
-1,125 Reduced 5.97%
17,735 $1.08 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $650,087 - $735,001
11,553 Added 158.11%
18,860 $1.13 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $162,596 - $174,076
3,029 Added 70.8%
7,307 $417,000
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $1,874 - $2,091
-39 Reduced 0.9%
4,278 $228,000
Q2 2017

Aug 11, 2017

BUY
N/A
4,317
4,317 $210,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.